British and American scientists are teaming up to search for the earliest signs of cancer in a bid to detect and treat the disease before it emerges. They plan to “give birth” to cancer in the lab to see exactly what it looks like “on day one”. It is just one of the research priorities… Read More »
About 80% of women experience vasomotor symptoms (VMS) – hot flashes and night sweats — as they transition into the menopause phase. For most, the symptoms are manageable, but for a sizeable subset of midlife women, these symptoms can negatively affect sleep, mood, and quality of life. While clinical guidelines suggest that menopausal vasomotor symptoms… Read More »
In this episode, Al interviews John Panigas, executive coach and author (recorded 8-21-19). Although John spent approximately 58 years struggling with depression, as the president of The Panigas Group of Companies, he helped grow them to become a $ 100 million business in twenty years. Hear how John met a therapist, received hypnotherapy, and finally… Read More »
Did you know that “rural America” encompasses 97 percent of the US land mass? And, 60 million people (20 percent of the U.S. population) live in rural America. This matters when it comes to healthcare. Because of the sheer distances, rural residents are increasingly isolated from reasonable geographic access to physicians, behavioral health professionals, outpatient… Read More »
Researchers at the John P. Hussman Institute for Human Genomics, led by Jacob L. McCauley, Ph.D., and Margaret A. Pericak-Vance, Ph.D., have completed a study creating a detailed genetic map of multiple sclerosis. Their study, “Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility,” was recently published in the journal Science. MS is… Read More »
FDA Approves Amzeeq (minocycline) Topical Foam for the Treatment of Moderate to Severe Acne Print this page REHOVOT, Israel and BRIDGEWATER, N.J., Oct. 18, 2019 (GLOBE NEWSWIRE) — Foamix Pharmaceuticals Ltd. (Nasdaq: FOMX) (“Foamix” or the “Company”), a specialty pharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has approved its novel… Read More »